These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bioequivalence of generic preparations of levothyroxine. Toft A Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682 [No Abstract] [Full Text] [Related]
6. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Wartofsky L Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412 [TBL] [Abstract][Full Text] [Related]
11. The emergence of levothyroxine as a treatment for hypothyroidism. Hennessey JV Endocrine; 2017 Jan; 55(1):6-18. PubMed ID: 27981511 [TBL] [Abstract][Full Text] [Related]
12. Levothyroxine sodium tablets: chemical equivalence and bioequivalence. Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889 [TBL] [Abstract][Full Text] [Related]
13. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. Green WL AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of thyroid preparations: the final word? Gibaldi M AAPS J; 2005; 7(1):E59-60. PubMed ID: 16493834 [No Abstract] [Full Text] [Related]
15. In vivo comparison of levothyroxine preparations. Ramos-Gabatin A; Jacobson JM; Young RL JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460 [No Abstract] [Full Text] [Related]
17. Levothyroxine and FDA bioequivalence ratings. Fox GN J Fam Pract; 2005 Feb; 54(2):179. PubMed ID: 15689298 [No Abstract] [Full Text] [Related]
18. Levothyroxine dosage and the limitations of current bioequivalence standards. Hennessey JV Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756 [No Abstract] [Full Text] [Related]
19. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles. Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941 [TBL] [Abstract][Full Text] [Related]